secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001493152-24-029227
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharma rebrands to TNF Pharmaceuticals; ticker changes to TNFA on Nasdaq
-----------------------------------------------------------------------------

- Name changed from MyMD Pharmaceuticals to TNF Pharmaceuticals effective July 22, 2024.
- Common stock began trading under new ticker 'TNFA' on Nasdaq effective July 24, 2024, replacing 'MYMD'.
- Rebranding aligns with therapeutic focus on TNF-alpha inhibition; lead candidate MYMD-1 unchanged.
- No change to CUSIP or shareholder action required; stockholder approval was not needed.
- Company plans mid-stage clinical trials of MYMD-1 for sarcopenia following positive Phase 2 results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224029227/0001493152-24-029227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224029227/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer